Expression Profiles of miRNA Subsets Distinguish Human Colorectal Carcinoma and Normal Colonic Mucosa

OBJECTIVES:MicroRNAs (miRNAs) are small, non-protein-coding RNA molecules that are commonly dysregulated in colorectal tumors. The objective of this study was to identify smaller subsets of highly predictive miRNAs.METHODS:Data come from population-based studies of colorectal cancer conducted in Utah and the Kaiser Permanente Medical Care Program. Tissue samples were available for 1,953 individuals, of which 1,894 had carcinoma tissue and 1,599 had normal mucosa available for statistical analysis. Agilent Human miRNA Microarray V.19.0 was used to generate miRNA expression profiles; validation of expression levels was carried out using quantitative PCR. We used random forest analysis and verified findings with logistic modeling in separate data sets. Important microRNAs are identified and bioinformatics tools are used to identify target genes and related biological pathways.RESULTS:We identified 16 miRNAs for colon and 17 miRNAs for rectal carcinoma that appear to differentiate between carcinoma and normal mucosa; of these, 12 were important for both colon and rectal cancer, hsa-miR-663b, hsa-miR-4539, hsa-miR-17-5p, hsa-miR-20a-5p, hsa-miR-21-5p, hsa-miR-4506, hsa-miR-92a-3p, hsa-miR-93-5p, hsa-miR-145-5p, hsa-miR-3651, hsa-miR-378a-3p, and hsa-miR-378i. Estimated misclassification rates were low at 4.83% and 2.5% among colon and rectal observations, respectively. Among independent observations, logistic modeling reinforced the importance of these miRNAs, finding the primary principal components of their variation statistically significant (P<0.001 among both colon and rectal observations) and again producing low misclassification rates. Repeating our analysis without those miRNAs initially identified as important identified other important miRNAs; however, misclassification rates increased and distinctions between remaining miRNAs in terms of classification importance were reduced.CONCLUSIONS:Our data support the hypothesis that while many miRNAs are dysregulated between carcinoma and normal mucosa, smaller subsets of these miRNAs are useful and informative in discriminating between these tissues.

[1]  N. Miller,et al.  mRNA/miRNA correlations in colorectal cancer: novel mechanisms in cancer initiation and progression , 2013, International Journal of Colorectal Disease.

[2]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[3]  Athanasios Fevgas,et al.  DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions , 2014, Nucleic Acids Res..

[4]  Kenichi Sugihara,et al.  Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters , 2012, Clinical Cancer Research.

[5]  Ramón Díaz-Uriarte,et al.  Gene selection and classification of microarray data using random forest , 2006, BMC Bioinformatics.

[6]  A. Jaiswal,et al.  miRNA–transcription factor interactions: a combinatorial regulation of gene expression , 2013, Molecular Genetics and Genomics.

[7]  K. Anderson,et al.  Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of bias. , 2000, Mutation research.

[8]  C. Qin,et al.  Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer , 2015, Scientific Reports.

[9]  Tommaso Mazza,et al.  Mirna Expression Profiles Identify Drivers in Colorectal and Pancreatic Cancers , 2012, PloS one.

[10]  H. Allgayer,et al.  MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer , 2008, Oncogene.

[11]  H. Brenner,et al.  MicroRNA Signatures: Novel Biomarker for Colorectal Cancer? , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[12]  George A Calin,et al.  Chemoprevention of Cigarette Smoke–Induced Alterations of MicroRNA Expression in Rat Lungs , 2010, Cancer Prevention Research.

[13]  T. Jin,et al.  MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression , 2014, Oncotarget.

[14]  Jing Cai,et al.  Prognostic Role of microRNA-21 in Colorectal Cancer: a Meta-Analysis , 2013, PloS one.

[15]  Ravinder Singh,et al.  Fast-Find: A novel computational approach to analyzing combinatorial motifs , 2006, BMC Bioinformatics.

[16]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[17]  Phillip A. Sharp,et al.  miRNA Profiling of Naïve, Effector and Memory CD8 T Cells , 2007, PloS one.

[18]  J. Potter,et al.  Energy balance and colon cancer--beyond physical activity. , 1997, Cancer research.

[19]  Cinzia Di Pietro,et al.  Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors , 2012, Journal of Molecular Medicine.

[20]  M. Slattery,et al.  Energy Balance and Rectal Cancer: An Evaluation of Energy Intake, Energy Expenditure, and Body Mass Index , 2003, Nutrition and cancer.

[21]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[22]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[23]  Tetsuo Yoshida,et al.  Functional screening identifies a microRNA, miR‐491 that induces apoptosis by targeting Bcl‐XL in colorectal cancer cells , 2009, International journal of cancer.

[24]  E. Miska,et al.  How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.

[25]  George A Calin,et al.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.

[26]  T. Okumura,et al.  MicroRNA profiles to predict postoperative prognosis in patients with small cell carcinoma of the esophagus. , 2015, Anticancer research.

[27]  Wei-Yin Loh,et al.  Classification and regression trees , 2011, WIREs Data Mining Knowl. Discov..

[28]  R. Wolff,et al.  MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression , 2016, Carcinogenesis.

[29]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[30]  Adele Cutler,et al.  Random forests for microarrays. , 2006, Methods in enzymology.

[31]  Stefano Volinia,et al.  MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets , 2009, The Journal of pathology.

[32]  Kellie J. Archer,et al.  Empirical characterization of random forest variable importance measures , 2008, Comput. Stat. Data Anal..

[33]  Esra Bozgeyik,et al.  Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. , 2015, Gene.

[34]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[35]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[36]  D. Amadori,et al.  MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) , 2010, Proceedings of the National Academy of Sciences.

[37]  Eivind Hovig,et al.  Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer , 2013, PloS one.

[38]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[39]  Sam Griffiths-Jones,et al.  miRBase: the microRNA sequence database. , 2006, Methods in molecular biology.

[40]  Robert P. Sheridan,et al.  Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..

[41]  Jun Yu,et al.  MicroRNA dysregulation in colorectal cancer: a clinical perspective , 2011, British Journal of Cancer.

[42]  D. Iliopoulos,et al.  MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice. , 2015, Gastroenterology.

[43]  E. Kure,et al.  Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing , 2012, PloS one.

[44]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[45]  R. Sanz-Pamplona,et al.  Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer , 2014, Molecular Cancer.

[46]  M. Gariboldi,et al.  miRNA Profiling in Colorectal Cancer Highlights miR-1 Involvement in MET-Dependent Proliferation , 2012, Molecular Cancer Research.

[47]  C. Croce,et al.  MicroRNAs in cancer: small molecules with a huge impact. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  X. Agirre,et al.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.